Skip to main navigation Skip to search Skip to main content

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

  • Australia Ovarian Cancer Study Group
  • , EMBRACE
  • , OCGN
  • , PRostate cancer Asso Ciation group To Investigate Cancer Associated aLterations in the genome
  • , GEMO Study Collaborators
  • , HEBON
  • Huntsman Cancer Institute
  • University of Cambridge
  • Melbourne School of Population and Global Health
  • University of Melbourne
  • Peter Maccallum Cancer Centre
  • Cancer Council Victoria
  • Antoni van Leeuwenhoek Hospital
  • Netherlands Cancer Institute
  • University Hospital Erlangen
  • University of California at Los Angeles
  • Institute of Cancer Research
  • Guy’s Hospital
  • Imperial College London
  • Department of Breast Surgery
  • University College London
  • University of Oxford
  • German Cancer Research Center
  • Heidelberg University 
  • State Research Institute Centre for Innovative Medicine
  • Latvian Biomedical Research and Study Centre
  • Beth Israel Deaconess Medical Center
  • Dana-Farber Cancer Institute
  • Brigham and Women’s Hospital
  • Harvard Medical School
  • Harvard T.H. Chan School of Public Health
  • University of Pretoria
  • University of Kansas
  • National Institute of Health Bogotá
  • APHP – Paris Saclay University
  • Institut Curie
  • INSERM U830
  • Université Paris Descartes
  • Centre de Recherche en Cancérologie de Lyon
  • Centre for Cancer Genetic Epidemiology
  • Department of Tumour Biology
  • Centre Léon Bérard
  • Georgetown University
  • CHRU Nouvel Hôpital Civil
  • University of Copenhagen
  • Copenhagen University Hospital – Herlev and Gentofte
  • Rigshospitalet
  • Danish Cancer Society
  • Aalborg University
  • Odense University Hospital
  • Centro de Investigación en Red de Enfermedades Raras
  • Centre for Biomedical Research on Rare Diseases (CIBERER)
  • IdISSC (El Instituto de Investigación Sanitaria del Hospital Clnico San Carlos)
  • Hospital Clinico San Carlos
  • Vall d'Hebron University Hospital
  • Barcelona University/Oral Health and Masticatory System Group (Bellvitge Biomedical Research Institute)
  • Institute Catala Oncologia
  • University of California-Irvine
  • Keck School of Medicine of USC
  • Cancer Prevention Institute of California
  • Beckman Research Institute of City of Hope
  • University of California at San Francisco
  • Cedars-Sinai Medical Center
  • Stanford University School of Medicine
  • H. Lee Moffitt Cancer Center & Research Institute
  • Mailman School of Public Health
  • Roswell Park Cancer Institute
  • Memorial Sloan-Kettering Cancer Center
  • Fox Chase Cancer Center
  • University of Pennsylvania Health System
  • MD Anderson Cancer Center
  • Texas Southern University
  • University of Texas Health Science Center at Houston
  • University of Pittsburgh
  • University of Pittsburgh Cancer Institute
  • University of Michigan, Ann Arbor
  • University of Warwick
  • Klinikum Rechts der Isar
  • Center for Integrated Oncology
  • University of Cologne
  • Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
  • University of Tübingen
  • Institute for Prevention and Occupational Medicine of the German Social Accident Insurance (IPA)
  • University of Helsinki
  • Hannover Medical School
  • Karolinska Institutet
  • Karolinska University Hospital
  • University of Eastern Finland
  • Kuopio University Hospital
  • VIB Department of Molecular Microbiology
  • KU Leuven
  • University Hospitals Leuven
  • Ghent University Hospital
  • University of Hamburg
  • Kliniken Essen-Mitte
  • Dr. Horst Schmidt Klinik GmbH
  • Charité Universitätsmedizin
  • FIRC Institute of Molecular Oncology
  • IRCCS Fondazione Istituto Nazionale per lo studio e la cura dei tumori - Milano
  • IRCCS Centro di Riferimento Oncologico - Aviano PN
  • European Institute of Oncology
  • Istituto Oncologico Veneto – IRCCS
  • U.O.C. di Oncologia
  • Portugese Oncology Institute
  • University of Porto
  • University Hospital of Pisa
  • Mayo Clinic Rochester, MN
  • QIMR Berghofer Medical Research Institute
  • Prince of Wales Hospital
  • McGill University Health Centre, Royal Victoria Hospital
  • McGill University
  • School of Clinical Medicine
  • Research Center
  • University of Southampton, Faculty of Medicine
  • BC Cancer
  • Oslo University Hospital-Radiumhospitalet
  • University of Oslo
  • Oslo University Hospital
  • Haukeland University Hospital
  • University of Bergen
  • Rutgers - The State University of New Jersey, New Brunswick
  • Yale University
  • Vanderbilt-Ingram Cancer Center
  • University of Oulu
  • Northern Finland Laboratory Centre NordLab
  • Erasmus MC
  • Mount Sinai Hospital of University of Toronto
  • University of Toronto
  • Leiden University
  • National Cancer Institute (NCI)
  • University of Glasgow
  • Glasgow Royal Infirmary
  • Cancer Research UK
  • Hong Kong Sanatorium & Hospital
  • The University of Hong Kong
  • Seoul National University
  • Sime Darby Medical Centre
  • University of Malaya
  • Aichi Cancer Center Hospital and Research Institute
  • Shanghai Cancer Institute
  • Masaryk Memorial Cancer Institute
  • Medical University of Vienna
  • The Gertner Institute
  • Carmel Medical Center and Technion Faculty of Medicine
  • N.N. Petrov Institute of Oncology
  • NorthShore University HealthSystem
  • The University of Chicago
  • Ohio State University
  • National Institute of Oncology
  • Dartmouth College
  • Duke University
  • Duke Cancer Institute
  • Radboud University Nijmegen
  • Radboud Institute for Molecular Life Sciences
  • University of New Mexico
  • Oregon Health and Science University
  • Lund University
  • Sahlgrenska University Hospital
  • Fred Hutchinson Cancer Research Center
  • Skane University Hospital
  • University of Sheffield
  • Pomeranian Medical University in Szczecin
  • Department of Pathology
  • M.Sklodowska-Curie Cancer Centre
  • Demokritos National Centre for Scientific Research

Research output: Contribution to journal › Article › peer-review

88 Scopus citations

Fingerprint

Dive into the research topics of 'BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers'. Together they form a unique fingerprint.
Sort by

Keyphrases

INIS

Medicine and Dentistry